Pharmaceutical compositions for angiogenic therapy

摘要

The use of a prostacyclin synthase gene and a HGF gene or a VEGF gene in the preparation of a medicament for angiogenic therapy; wherein the therapy is preferably for treating or preventing ischemic disease of arterial disease such as arteriosclerosis obliterans, myocardial infarction, angina pectoris, cardiomyopathy and cerebrovascular disease.